The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors

Expert Opinion On Drug Discovery

dc.creatorReyes-Parada, Miguel
dc.creatorIturriaga-Vasquez, Patricio
dc.date2018-12-07T13:33:48Z
dc.date2022-07-07T21:40:52Z
dc.date2015
dc.date2018-12-07T13:33:48Z
dc.date2022-07-07T21:40:52Z
dc.date2016
dc.date.accessioned2023-08-22T01:16:38Z
dc.date.available2023-08-22T01:16:38Z
dc.identifier1150615
dc.identifier1150615
dc.identifierhttps://hdl.handle.net/10533/232743
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8304998
dc.descriptionIntroduction: Polypharmacology, which refers to the ability of a molecule to simultaneously interact with multiple target proteins, is shifting the drug discovery process from a 'one-drug-one-target' paradigm to a conceptual framework in which the multita
dc.descriptionRegular
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111557
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttps://www.tandfonline.com/doi/abs/10.1080/17460441.2016.1227317?journalCode=iedc20
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors
dc.titleExpert Opinion On Drug Discovery
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución